HDAC1 and allergic rhinitis: The treatment with antigen-specific immunotherapy and administration of probiotic C. butyricum reduce the serum levels of Th2 cytokines by increasing Trek-1 expression levels and decreasing HDAC1 in the nasal mucosa of allergic rhinitis patients (23).